The Efficacy and Safety Study of Dabigatran and Warfarin to Non-valvular Atrial Fibrillation Patients
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 210 participants.
Also called NCT02646267
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 210 participants
- Registry
-
NCT02646267
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT02646267. Randomized; no masking; primary purpose treatment. Start 2016-03 (registry gives no type); primary completion 2018-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- The Efficacy and Safety Study of Dabigatran and Warfarin to Non-valvular Atrial Fibrillation Patients
- Condition
- Atrial Fibrillation
- Intervention (Drug)
- standard intensity warfarin
- Intervention (Drug)
- low intensity warfarin
- Intervention (Drug)
- dabigatran etexilate
- Lead sponsor
- The First Affiliated Hospital with Nanjing Medical University
Record details
- Record id
cardio:ct-nct02646267- Content hash
9bf6629512bf37a969f264d916b825cf14f5967f1ee7963c95c377372b4fd640